Fed. Circ. Trims Bio-Rad IP Win, But $24M Verdict Stays
The Federal Circuit on Monday upheld a decision out of Delaware that 10X Genomics should pay Bio-Rad and the University of Chicago $24 million for infringing a DNA manipulation patent, but...To view the full article, register now.
Already a subscriber? Click here to view full article